Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Virpax Pharmaceuticals, Inc. (VRPX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 10-K | S-1 | S-1 | S-1/A |
| Revenues | 100.0% | 100.0% | | | |
| Cost of goods sold | 0.0% | 0.0% | | | |
| Gross profit | 100.0% | 100.0% | | | |
| Research and development | 47.6% | 36.0% | | | |
| General and administrative | 51.7% | 60.2% | | | |
| EBIT | -96.0% | -85.6% | | | |
| Pre-tax income | -95.8% | -89.6% | | | |
| Income taxes | 0.0% | 0.0% | | | |
| Net income | -95.8% | -89.6% | | | |
|